acetylcholine ach suggested exert various pathophysiological activities airways addition bronchoconstriction archetypal neurotransmitter components cholinergic expressed number cells airways ach released cells affect fibroblasts fb inflammatory cells lung tissue tiotropium bromide antimuscarinic drug marketed brand spiriva treatment chronic obstructive pulmonary disease copd proven direct bronchodilatory activity recent evidence suggests tiotropium able reduce frequency exacerbations attenuate decline lung function improving course obstructive airway diseases aim present study investigate effects tiotropium proliferation primary human fb isolated biopsies lung fibrosis patients myofibroblasts myfb derived cells human lung fb cell line acted control expression muscarinic receptor subtypes m1 m2 m3 demonstrated cell types acetylcholine stimulated proliferation cells investigated tiotropium inhibited proliferation fb myfb maximum effect NUMBER nm results suggest cholinergic stimuli mediated muscarinic receptors contribute remodeling processes chronic airway disease tiotropium bromide beneficial influence airway remodeling processes chronic airway diseases antiproliferative effects fibroblasts myofibroblasts vagally induced non neuronal non neuronal day ach induced rt pcr concentration dependently ach induced